Lionel Nobs

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial

Ross A. Soo, Ji‐Youn Han, Urania Dafni et al. · Annals of Oncology · 2021 · 111 citations · Full text

Advanced Nsclc, Booster Trial, Novel Therapy +8

<i>empty spiracles</i>is required for the development of olfactory projection neuron circuitry in<i>Drosophila</i>

Robert Lichtneckert, Lionel Nobs, Heinrich Reichert · Development · 2008 · 29 citations

Circuit Neuroscience, Genetics, Molecular Genetics +22

Cyclin D1 is required for proliferation of olig2‐expressing progenitor cells in the injured cerebral cortex

Lionel Nobs, Sigrun Nestel, Ákos Kulik et al. · Glia · 2013 · 17 citations · Full text

Stage-specific requirement for cyclin D1 in glial progenitor cells of the cerebral cortex

Lionel Nobs, Constanze Baranek, Sigrun Nestel et al. · Glia · 2014 · 10 citations